Anthony Zook

Mr. Anthony P.
Zook is an Independent Director at Adaptin Bio, Inc., a Chief Executive Officer & Director at NeoGenomics, Inc., a Chairman at Algorithm Sciences, Inc. and an Executive Chairman at Voltron Therapeutics, Inc. He is on the Board of Directors at Adaptin Bio, Inc., NeoGenomics, Inc., ViralClear Pharmaceuticals, Inc. and Healthcare Leadership Council.
Mr. Zook was previously employed as an Independent Director by BioSig Technologies, Inc., a Chief Executive Officer by Innocoll AG, a Chief Executive Officer & Member-Supervisory Board by Innocoll Holdings Plc, a Chief Executive Officer by Innocoll Biotherapeutics, a Chief Executive Officer & Director by VIVUS, Inc., an Executive Vice President-Global Commercial by AstraZeneca PLC, a President & Chief Executive Officer by Astra USA, Inc., a President & Chief Executive Officer by AstraZeneca Pharmaceuticals LP, a Director-Pennsylvania Division by American Cancer Society, Inc., a Partner by Lucius Partners LLC, and a President by MedImmune Ventures, Inc. He also served on the board at Inhibikase Therapeutics, Inc., AltheRx, Inc., Melinta Subsidiary Corp., First State Innovation, Inc., Frostburg State University, MedImmune LLC, National Pharmaceutical Council and Pharmaceutical Research & Manufacturers of America.
He received his undergraduate degree from Frostburg State University and an undergraduate degree from The Pennsylvania State University.